Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ecphora Capital is a venture capital firm located in Baltimore, Maryland, founded by Deborah Hemingway, Ph.D. The firm focuses on the medical technology sector, particularly in the Maryland-DC-Virginia region, which is recognized as a hub for biotech innovation. Ecphora Capital supports medtech startups through a structured, data-driven program designed to assess and enhance their potential for success.
Currently, Ecphora Capital operates with a team that includes experienced professionals in various roles, contributing to its mission of transforming healthcare systems. The firm emphasizes its strategic partnerships with leading medical and research institutions, which provide valuable resources and access to early-stage companies. These collaborations are pivotal in fostering innovation within the medtech sector.
Ecphora Capital's commitment to supporting healthcare innovation is evident in its structured approach to investment and its focus on leveraging data to improve patient outcomes. The firm continues to evolve, adapting to the changing landscape of medical technology and maintaining its position as a key player in the industry.
Ecphora Capital invests primarily in the healthcare sector, with a strong emphasis on medical devices, biotechnology, digital health, and healthtech. The firm targets startups at the pre-seed, seed, and Series A funding stages, providing them with the necessary capital and support to grow. Ecphora Capital employs a proprietary startup program that evaluates ventures over a three-month period, focusing on critical success parameters that are essential for transforming healthcare systems.
The firm seeks to invest in innovative solutions that enhance patient treatment and improve healthcare delivery. This includes technologies that utilize data analytics, artificial intelligence, telemedicine, and remote patient monitoring. Ecphora Capital's investment strategy is designed to identify and support startups that have the potential to make significant impacts in the healthcare industry.
Ecphora Capital has established strategic partnerships with several prominent organizations that enhance its investment capabilities and access to early-stage companies. Notable partnerships include:
These partnerships not only provide Ecphora Capital with access to promising startups but also foster innovation in the medtech sector, aligning with the firm's investment focus.
Deborah Hemingway: Managing Partner. Deborah has extensive experience in the medical technology sector and leads the firm's investment strategy.
Jeremy Neilson: Managing Director, Head of Operations. Jeremy oversees the operational aspects of the firm, ensuring efficient processes and execution.
Charles Kirby: Venture Partner. Charles brings expertise in venture capital and has a strong background in healthcare investments.
Sathya Janardhanan: Venture Partner. Sathya focuses on identifying and evaluating potential investment opportunities in the medtech space.
Lauren Renz: Director of Investor Relations. Lauren manages relationships with investors and stakeholders, facilitating communication and engagement.
Cayden Johnson: Capital Campaign Strategist. Cayden is responsible for developing strategies to attract capital to the firm.
Nick Stewart: General Counsel. Nick provides legal guidance and support for the firm's operations and investments.
Joel Ruffini: Special Counsel. Joel assists with legal matters and compliance related to the firm's investments.
Aiza Torres: Executive Assistant. Aiza supports the team with administrative tasks and coordination.
Tom Coale: Government Relations. Tom engages with governmental bodies and stakeholders to advocate for the firm's interests.
Startups interested in pitching to Ecphora Capital should submit their proposals through the firm's website at ecphoracapital.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and team qualifications.
Founders should expect a response within a reasonable timeframe, although specific timelines are not disclosed. Warm introductions are preferred, particularly from trusted sources within the healthcare or venture capital sectors.
Ecphora Capital runs a proprietary startup program that evaluates early-stage ventures in the medical technology sector. This program assesses startups over a three-month period, focusing on critical success parameters essential for transforming healthcare systems.
Startups participating in this program gain access to valuable resources, mentorship, and potential funding opportunities, positioning them for success in the competitive healthcare landscape.
As of October 2023, Ecphora Capital has been actively engaging with the medtech ecosystem through its strategic partnerships with organizations such as The LaunchPort, Johns Hopkins University, and the National Institutes of Health. These collaborations aim to foster innovation and provide access to early-stage companies in the healthcare sector.
Recent activities include the expansion of their proprietary startup program, which assesses startups on critical success parameters over a three-month period. This initiative is designed to enhance the firm's ability to identify and support high-potential ventures in the medical technology space.
What are Ecphora Capital's investment criteria?
Ecphora Capital focuses on healthcare startups, particularly in medical devices, biotechnology, digital health, and healthtech. The firm invests at the pre-seed, seed, and Series A stages, looking for innovative solutions that enhance patient treatment and healthcare systems.
How can startups apply or pitch to Ecphora Capital?
Startups can pitch to Ecphora Capital through their website at ecphoracapital.com. It is advisable to include a detailed deck that outlines the business model, market opportunity, and team background.
What makes Ecphora Capital different from other venture capital firms?
Ecphora Capital differentiates itself through its structured, data-driven startup program that assesses ventures over a three-month period. This program focuses on critical success parameters that are essential for transforming healthcare systems.
What is the geographic scope of Ecphora Capital's investments?
The firm primarily invests in the United States, with a strong emphasis on the Maryland-DC-Virginia region, which is known for its biotech innovation.
What kind of post-investment involvement does Ecphora Capital have?
Ecphora Capital actively engages with its portfolio companies, leveraging its partnerships with leading medical and research institutions to provide resources and support for growth.
What is the typical check size for investments made by Ecphora Capital?
While specific check sizes are not disclosed, Ecphora Capital focuses on early-stage funding, which typically aligns with pre-seed, seed, and Series A investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.